Your browser doesn't support javascript.
Clozapine, neutropenia and Covid-19: should clinicians be concerned? 3 months report.
Bonaccorso, Stefania; Ricciardi, Angelo; Ouabbou, Sophie; Theleritis, Christos; Ross-Michaelides, Arabella; Metastasio, Antonio; Stewart, Neil; Mohammed, Marwa; Schifano, Fabrizio.
  • Bonaccorso S; Highgate Mental Health Centre, Camden & Islington NHS Foundation Trust, Dartmouth Park Hill, N19 5 NX, UK.
  • Ricciardi A; University College London, Gower St, Bloomsbury, London, WC1E 6BT, UK.
  • Ouabbou S; King's College London, Denmark Hill, Brixton, London, SE5 9RS, UK.
  • Theleritis C; University of Hertfordshire, De Havilland Campus, Mosquito Way, Hatfield, AL10 9EU, UK.
  • Ross-Michaelides A; DSM ASL Roma 1, CSM Via Monte Tomatico, 9, 00141, Rome, Italy.
  • Metastasio A; Highgate Mental Health Centre, Camden & Islington NHS Foundation Trust, Dartmouth Park Hill, N19 5 NX, UK.
  • Stewart N; Highgate Mental Health Centre, Camden & Islington NHS Foundation Trust, Dartmouth Park Hill, N19 5 NX, UK.
  • Mohammed M; 1st Psychiatry Dept, National and Kapodistrian University of Athens, Greece.
  • Schifano F; Highgate Mental Health Centre, Camden & Islington NHS Foundation Trust, Dartmouth Park Hill, N19 5 NX, UK.
Brain Behav Immun Health ; 13: 100212, 2021 May.
Article in English | MEDLINE | ID: covidwho-1051476
ABSTRACT

BACKGROUND:

Clozapine is among the most effective antipsychotics used for treatment resistant schizophrenia. Adverse reactions to clozapine include neutropenia. In March 2020, at the start of the Coronavirus -19 pandemic, clinicians raised concerns regarding continuation of antipsychotic treatment, and specifically of clozapine, in patients with coronavirus disease. We aimed here at providing a short report focusing on the association between neutropenia and clozapine in a case series of psychiatric inpatients diagnosed with COVID-19. PATIENTS &

METHODS:

We retrospectively inspected data of 10 patients on clozapine, admitted to Highgate Mental Health Centre, Camden & Islington NHS Foundation Trust, between March and July 2020; selection was based on their COVID-19 positive PCR test. We used a linear regression model to estimate whether there was a significant drop in the neutrophil count during SARS-CoV-2 infection.The analysis was done in R using a linear regression to the origin.

RESULTS:

Data were collected on 10 patients, of which 7 were males. During COVID-19 infection, neutrophils' count (ANC) was 4.13 â€‹× â€‹109/l (SD â€‹= â€‹2.70) which constituted a significant drop from a baseline value of 5.2 â€‹× â€‹109/l (SD â€‹= â€‹2.24). The mean relative reduction in ANC was -0.2729 (SD â€‹= â€‹0.1666). The beta value of 0.8377 obtained with the linear regression showed that ANC values during SARS-CoV-2 infection were 83.77% of the baseline ANC showing that within the two time points there was a decrease of 16.23%. The linear regression had a pvalue â€‹= â€‹8.96 â€‹× â€‹10-8 and an adjusted R2 of 95.94% which shows that the variability of the data is very well explained by the model. We also compared baseline ANC with ANC values approximately a month after resolution of the infection and results indicate that ANC values return to a 95% of baseline.

CONCLUSIONS:

Clinicians should bear in mind that a significant drop in neutrophils' count may occur in patients taking clozapine and affected from a SARS-CoV-2 infectionand that this drop is only transitory.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Brain Behav Immun Health Year: 2021 Document Type: Article Affiliation country: J.bbih.2021.100212

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Brain Behav Immun Health Year: 2021 Document Type: Article Affiliation country: J.bbih.2021.100212